Posts
September 28 2016
Apricus BioSciences Inc. announced the closing of their Registered Direct offering in the amount of $3,734,286. EG&S acted as counsel to the Placement Agent.
September 21 2016
OurCrowd announced the closing of their Series C Offering in the amount of $71,000,000. EG&S acted as counsel to OurCrowd.
September 19 2016
Rexahn Pharmaceuticals, Inc. announced the closing of their Registered Direct offering in the amount of $6,000,000. EG&S acted as counsel to the Placement Agent.
September 15 2016
CytoDyn, Inc. announced the closing of their Registered Direct offering in the amount of $10,000,000. EG&S acted as counsel to the Placement Agent.
September 14 2016
Cancer Genetics, Inc. announced the closing of their Registered Direct offering in the amount of $5,500,000. EG&S acted as counsel to the Placement Agent.
September 14 2016
Real Goods Solar, Inc. announced the closing of their Underwritten offering in the amount of $2,407,125. EG&S acted as counsel to the Underwriter.
September 14 2016
PFO Global, Inc. announced the closing of their PIPE offering in the amount of $350,000. EG&S acted as counsel to the Investor.
September 12 2016
Medigus Ltd. announced the closing of their Registered Direct offering in the amount of $1,472,000. EG&S acted as counsel to the Investor.